The value of serum IL-4 to predict the survival of MDS patients

Table 2 Characteristics at baseline of 120 newly diagnosed MDS patients

Characteristic	All cases (n = 114)	IL-4 < 5.155 (n = 85)	IL-4 > 5.155 (n = 29)	P
Age				0.038
≥ 65	54	42	12
< 65	60	43	17
Gender				0.083
Male	79	60	19
Female	35	25	10
N (*10⁹/L)				0.080
≥ 0.8	87	62	25
< 0.8	27	23	4
HB (g/L)				0.062
≥ 100	20	14	6
< 100	94	71	23
PLT (*10⁹/L)				0.092
≥ 100	36	24	12
< 100	78	61	17
Cytopenia series
0–1	33	22	11	0.078
2–3	81	63	18
Bone marrow primitive cell ratio (%)				0.087
≤ 2	79	56	23
> 2	35	29	6
Karyotype				0.095
Good	80	59	21
Bad	34	26	8

HB: hemoglobin , N: neutrophil, PLT: platelet, karyotype good: − Y, 11q⁻ (excellent); normal karyotype, 5q⁻, 12p⁻, 20q⁻, 5q⁻ with another karyotype abnormality attached (good); 7q⁻, + 8, + 19, i (17q), chromosomal abnormalities in other or 2 independent clones (moderate). Karyotype bad: − 7, inv(3)/t(3q)/dcl(3q), − 7/7q⁻ with one additional abnormality, 3 complex abnormalities (poor), ≥ 3 complex abnormalities (very poor)

ISSN: 2047-783X